The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTrufin Plc Regulatory News (TRU)

Share Price Information for Trufin Plc (TRU)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 68.50
Bid: 68.00
Ask: 69.00
Change: 2.50 (3.76%)
Spread: 1.00 (1.471%)
Open: 68.00
High: 69.00
Low: 65.50
Prev. Close: 66.50
TRU Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Sale of Majority Holding in Vertus

5 Oct 2023 07:00

RNS Number : 7422O
TruFin PLC
05 October 2023
 

5 October 2023

TruFin plc 

("TruFin" or the "Company")

 

SALE OF MAJORITY HOLDING IN VERTUS

Further to the Company's announcement on 21 August 2023, TruFin announces that it has completed the disposal of its 53.8% equity holding in Vertus Capital Ltd ("Vertus"), a specialist lender to independent financial advisers, for cash consideration of £3.2m following the acquisition of Vertus by Enable Partners Holdings Limited ("Enable") (the "Disposal").

For the year ended 31 December 2022, Vertus recorded £213k of profit before tax and contributed £162k of profit before tax to the Company's performance for the year. As at 30 June 2023, the Company's share of Vertus' net assets and associated goodwill was £3.2m. Proceeds from the disposal will be used to provide additional working capital for the Company and allow for incremental capital allocations to Oxygen and Satago based on ROI expectations.

Watrium AS ("Watrium"), a 22.8% shareholder in the Company, has co-invested in Enable, alongside Explore Equity II SCSp ("Explore") as part of the transaction, taking a 48.89% stake in Enable. Watrium is also a minority LP investor in Explore. By virtue of Watrium's investment in Enable, the Disposal constitutes a related party transaction for the purpose of AIM Rule 13 and accordingly, the Directors of TruFin (other than Anders Wilhelmsen, being a representative of Watrium on the Board of TruFin) having consulted with the Company's Nominated Adviser, Liberum, consider that the terms of the Disposal and Watrium's participation in it are fair and reasonable insofar as the shareholders of the Company are concerned.

James van den Bergh, Chief Executive Officer, TruFin, said:

"Oxygen, Satago and Playstack have made strong progress in executing their strategies over the last 24 months. Oxygen and Satago are both critical infrastructure software providers whilst Playstack is a highly focused games publisher with an enviable pipeline of games secured. The disposal of Vertus, at an attractive valuation, simplifies and focuses the TruFin business. The sale proceeds further strengthen TruFin's robust balance sheet as we look forward to continued momentum at Oxygen, Satago and Playstack.

It has been a pleasure to work with Matt Marais and his team over the last few years. Through hard work and entrepreneurship they have succeeded in building a strong brand as a niche capital provider to the IFA community, which will act as a springboard for their exciting expansion plans. We wish Matt, Enable and Watrium all the best for the future. "

Matt Marais, Chief Executive Officer, Vertus, said:

"We would like to thank James and the TruFin team for their support and the wise counsel they have provided during their time as a strategic partner to Vertus. The acquisition by Enable will provide us with the investment to support the next phase of our exciting growth plans."

Enquiries:

TruFin plc James van den Bergh, Chief Executive OfficerKam Bansil, Investor Relations

0203 743 134007779 229508

 

Liberum Capital Limited (Nominated Adviser and Corporate broker) Chris ClarkeEdward Thomas

0203 100 2000

About TruFin plc:

TruFin plc is the holding company of an operating group comprising four growth-focused technology businesses operating in niche markets: early payment provision, invoice finance, IFA finance and mobile games publishing. The Company was admitted to AIM in February 2018 and trades under the ticker symbol: TRU. More information is available on the Company website: www.TruFin.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DISFFFVIIFLSIIV
Date   Source Headline
12th Apr 20247:01 amRNSBlock Admission Application
12th Apr 20247:00 amRNSGrant of share awards under LTIP
2nd Apr 20247:00 amRNSAppointment of Director to the Board of Playstack
26th Mar 20247:01 amRNSSale of Interact platform
25th Mar 20247:00 amRNSSatago signs contract with Bank of Ireland Finance
19th Mar 20247:00 amRNSNotice of Results and Investor Presentation
18th Mar 20247:00 amRNSPlaystack announces over 1m units sold for Balatro
12th Mar 202411:07 amRNSHolding(s) in Company
22nd Feb 20247:00 amRNSPlaystack releases its fastest selling game
8th Feb 20247:00 amRNSTrading Update
4th Jan 20247:00 amRNSTrading Update
20th Dec 20239:40 amRNSHolding(s) in Company
14th Dec 20237:00 amRNSAppointment of INED to the Board of Oxygen
21st Nov 20237:00 amRNSPlaystack enters into LoI for sale of Interact
9th Nov 20237:00 amRNSOxygen Finance acquisition of bidstats.uk
18th Oct 20234:19 pmRNSHolding(s) in Company
5th Oct 20237:00 amRNSSale of Majority Holding in Vertus
29th Sep 20237:00 amRNSHalf-year Report
28th Sep 202312:07 pmRNSResult of AGM
14th Sep 20238:00 amRNSPlaystack releases award-winning game - AK-xolotl
29th Aug 20236:19 pmRNSNotice of AGM
21st Aug 20237:00 amRNSNon-Binding Offer for Vertus
28th Jul 20237:00 amRNSGrant of Share Awards under LTIP
18th Jul 20238:59 amRNSHolding(s) in Company
18th Jul 20238:58 amRNSHolding(s) in Company
18th Jul 20238:55 amRNSHolding(s) in Company
10th Jul 202312:03 pmRNSResult of GM and Result of Placing and Open Offer
23rd Jun 20237:00 amRNSResult of Placing and Notice of General Meeting
22nd Jun 20234:45 pmRNSProposed Placing and Open Offer
18th May 20233:04 pmRNSHolding(s) in Company
26th Apr 20237:00 amRNSOxygen Finance secures six Early Payment contracts
15th Mar 20237:00 amRNSFinal Results for the year ended 31 December 2022
28th Feb 20235:43 pmRNSHolding(s) in Company
23rd Jan 20237:00 amRNSStatement re Satago
20th Jan 20237:00 amRNSStatement regarding Satago and Trading Update
22nd Dec 20227:00 amRNSRejected Indicative Offer for Oxygen
15th Nov 20227:00 amRNSOxygen surpasses £1b in early payment provision
3rd Nov 20227:00 amRNSPlaystack releases new console game
20th Oct 20227:00 amRNSSatago signs agreement with Sage
10th Oct 20227:00 amRNSNotice of Capital Markets Day
30th Sep 20227:00 amRNSPDMR Notification
20th Sep 20227:00 amRNSInterim Results
12th Sep 20227:00 amRNSNotice of Capital Markets Day
25th Aug 20229:37 amRNSHolding(s) in Company
29th Jul 20229:00 amRNSPrice Monitoring Extension
29th Jul 20227:00 amRNSSatago signs commercial agreement with Lloyds
1st Jul 20227:00 amRNSHolding(s) in Company
9th Jun 20227:00 amRNSSatago partnership with Sage and Lloyds
7th Jun 202211:19 amRNSResult of AGM
6th Jun 20227:00 amRNSStatement re Playstack

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.